EGM
FSTX

Engineers Gate Manager’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Engineers Gate Manager’s Portfolio FSTX Stock Details FSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-10,700
Closed -$54K – 2469
2021
Q4 		$54K Buy
+10,700
New +$64.5K ﹤0.01% 1863

Other funds holding FSTX

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $122M AUM 26.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Engineers Gate Manager's FSTX Position: Q1 2022 in Review

Engineers Gate Manager sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q1 2022, closing a stake of 10,700 shares — an estimated $54K sold.

Engineers Gate Manager first reported a position in FSTX in Q4 2021 and held it in 1 quarter. The position peaked at $54K in Q4 2021. 40 funds tracked by Wall St. Rank hold FSTX as of Q1 2022.

  • Engineers Gate Manager reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Engineers Gate Manager sold 10,700 F-star Therapeutics, Inc. Common Stock shares in Q1 2022, an estimated $54K.
  • Engineers Gate Manager first reported a position in F-star Therapeutics, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • Engineers Gate Manager's F-star Therapeutics, Inc. Common Stock position peaked at $54K in Q4 2021.
  • 40 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q1 2022.

Based on Engineers Gate Manager's 13F filing for Q1 2022, filed 16 May 2022.